Pharmaceutical Patent Analyst

276 papers and 2.2k indexed citations i.

About

The 276 papers published in Pharmaceutical Patent Analyst in the last decades have received a total of 2.2k indexed citations. Papers published in Pharmaceutical Patent Analyst usually cover Molecular Biology (98 papers), Economics and Econometrics (49 papers) and Management of Technology and Innovation (43 papers) specifically the topics of Pharmaceutical Economics and Policy (43 papers), Intellectual Property and Patents (43 papers) and Biomedical Ethics and Regulation (21 papers). The most active scholars publishing in Pharmaceutical Patent Analyst are Hardeep Singh Tuli, Paolo Pevarello, Peter J. H. Scott, Sandeep Kumar and Allen F. Brooks.

In The Last Decade

Fields of papers published in Pharmaceutical Patent Analyst

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Pharmaceutical Patent Analyst. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Pharmaceutical Patent Analyst

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Pharmaceutical Patent Analyst. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Pharmaceutical Patent Analyst with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025